Articles tagged with Colorectal Cancer
A new study finds that positron emission tomography (PET) can detect additional tumors in patients with warning signs of colorectal cancer. PET imaging confirmed disease in 15 out of 17 patients with tumors, while those with negative results remained cancer-free for at least nine months.
Researchers found that relatives of individuals with colon polyps have a slightly less than doubling of risk compared to the general population, rising to about 10-12% over a lifetime. The study suggests that these individuals should receive colonoscopy instead of sigmoidoscopy for screening.
Researchers at The Wistar Institute have identified a key role for the GA733 antigen in inhibiting colorectal cancer cell invasion. The discovery has led to the development of an antibody that increases survival rates for CRC patients.
Researchers at Rockefeller University are conducting a study to examine the potential of three plant-derived compounds - curcumin, rutin, and quercetin - to prevent colorectal cancer. The study aims to determine whether these compounds can safely inhibit the development of colon polyps and reduce cancer risk.
Researchers at Roswell Park Comprehensive Cancer Center found that p53 mutation does not trigger cancer development for colorectal cancer, contrary to long-held dogma. Instead, they identified a mysterious enigma controlling cell progression to cancerous states.
A new drug, CPT-11, has been approved by the FDA for treating colorectal cancer. Researchers plan to enroll approximately 660 patients in a Phase III trial to evaluate its effectiveness as a first-line treatment.